Surgical sleeve gastrectomy for treatment of obesity is a bariatric procedure that permanently reduces stomach size to help individuals with severe obesity achieve sustained weight loss. Also known as vertical sleeve gastrectomy (VSG), the operation removes approximately 75–80% of the stomach laparoscopically, leaving a narrow, tube-shaped 'sleeve'. This restricts food intake and reduces hunger hormones, leading to significant metabolic improvements. In the UK, sleeve gastrectomy is one of the most commonly performed weight loss surgeries, offered through the NHS and private healthcare to eligible patients who meet specific clinical criteria established by NICE guidance.

What Is Sleeve Gastrectomy Surgery?

Sleeve gastrectomy, also known as vertical sleeve gastrectomy (VSG), is a bariatric surgical procedure designed to treat severe obesity by permanently reducing the size of the stomach. During the operation, approximately 75–80% of the stomach is removed laparoscopically, leaving a narrow, tube-shaped or 'sleeve' portion that resembles a banana. This smaller stomach initially holds around 100–150 millilitres of food, though capacity may increase gradually over time. In comparison, the original stomach capacity is approximately 1,000–1,500 millilitres.

The procedure works through two primary mechanisms. Firstly, the reduced stomach capacity restricts the volume of food that can be consumed at one time, leading to earlier satiety and decreased overall caloric intake. Secondly, the surgery removes the fundus of the stomach, which produces ghrelin—often referred to as the 'hunger hormone'. This hormonal change results in reduced appetite and improved metabolic function, contributing to sustained weight loss.

Sleeve gastrectomy is typically performed under general anaesthesia using minimally invasive laparoscopic techniques, involving several small incisions rather than one large opening. The operation usually takes between one and two hours, and most patients remain in hospital for one to three days post-operatively. Unlike gastric bypass procedures, sleeve gastrectomy does not involve rerouting the intestines or implanting adjustable devices.

In the UK, sleeve gastrectomy has become one of the most commonly performed weight loss surgeries within the NHS and private healthcare settings, according to National Bariatric Surgical Registry (NBSR) data. The procedure is irreversible, as the removed portion of the stomach cannot be restored. Sleeve gastrectomy is major surgery and carries inherent risks that require careful consideration and discussion with your bariatric team.

Who Is Eligible for Sleeve Gastrectomy in the UK?

Eligibility for sleeve gastrectomy in the UK is determined by specific clinical criteria established by the National Institute for Health and Care Excellence (NICE). According to NICE guidance (CG189), bariatric surgery should be considered for adults with a body mass index (BMI) of 40 kg/m² or above, or those with a BMI of 35 kg/m² or above who have significant obesity-related comorbidities such as type 2 diabetes mellitus, hypertension, obstructive sleep apnoea, or non-alcoholic fatty liver disease.

In certain circumstances, surgery may be considered at lower BMI thresholds. For individuals of Asian family origin, the BMI criteria are adjusted downward by 2.5 kg/m² to account for differences in body composition and metabolic risk. Additionally, expedited assessment for bariatric surgery may be offered to people with recent-onset type 2 diabetes and a BMI of 35 kg/m² or above.

The UK pathway typically begins with GP referral to a Tier 3 specialist weight management service. Before proceeding with surgery, patients must demonstrate that they have undertaken all appropriate non-surgical measures to achieve weight loss, including supervised diet programmes, increased physical activity, and behavioural interventions within a multidisciplinary team (MDT) setting. Candidates must also be fit for anaesthesia and surgery, with acceptable operative risk following comprehensive medical assessment.

Smoking cessation is strongly advised before surgery to reduce complications, and many services require patients to stop smoking for a specified period pre-operatively. A pre-operative liver-reduction diet (typically a low-calorie liquid diet for two weeks) is commonly used in UK practice to shrink the liver and improve surgical safety.

Psychological evaluation is an essential component of the pre-operative assessment. Patients must demonstrate understanding of the procedure, realistic expectations regarding outcomes, and commitment to lifelong dietary modifications and follow-up care. Mental health conditions and eating disorders should be assessed and optimised rather than being absolute contraindications. Active substance misuse and inability to engage with long-term lifestyle changes require careful evaluation. Multidisciplinary team assessment—including surgeons, dietitians, psychologists, and specialist nurses—ensures that sleeve gastrectomy is appropriate and that patients receive comprehensive support throughout their weight loss journey. Following assessment, suitable patients are referred to a Tier 4 bariatric surgical service for consideration of surgery.

Benefits and Expected Weight Loss Outcomes

Sleeve gastrectomy offers substantial and sustained weight loss for individuals with severe obesity. Clinical evidence demonstrates that patients typically lose 50–70% of their excess body weight within the first 12–24 months following surgery. For example, a patient weighing 140 kg with a target weight of 80 kg (60 kg excess weight) might expect to lose approximately 30–42 kg during this period. Weight loss is most rapid in the first six months, then continues at a slower rate before stabilising.

Beyond weight reduction, sleeve gastrectomy produces significant improvements in obesity-related comorbidities. Type 2 diabetes shows notable response, with many patients achieving remission or substantial improvement in glycaemic control, often reducing or eliminating the need for diabetes medications. UK and European data suggest remission rates of approximately 40–60% at one to two years for sleeve gastrectomy, though remission rates may decline over time and are generally lower than those seen with gastric bypass. Similarly, hypertension, dyslipidaemia, obstructive sleep apnoea, and joint pain frequently improve or resolve following sustained weight loss.

The metabolic benefits extend beyond simple caloric restriction. The hormonal changes resulting from ghrelin reduction and altered gut hormone secretion contribute to improved insulin sensitivity, reduced cardiovascular risk, and enhanced quality of life. Patients commonly report increased mobility, improved self-esteem, better sleep quality, and greater ability to participate in daily activities and employment.

Long-term outcomes are generally favourable when patients adhere to dietary recommendations and attend regular follow-up appointments. Research indicates that most individuals maintain 50–60% excess weight loss at five years post-operatively. However, some weight regain is possible, particularly if dietary discipline lapses or gradual dilation of the gastric sleeve occurs over time. Ongoing nutritional monitoring, physical activity, and behavioural support are essential to optimise and maintain results. It is important to recognise that sleeve gastrectomy is a tool to facilitate weight loss rather than a standalone cure, requiring lifelong commitment to healthy lifestyle practices.

Risks and Potential Complications of the Procedure

Whilst sleeve gastrectomy is generally considered safe, it is major surgery and carries inherent risks that patients must understand before proceeding. Early complications (occurring within 30 days) include bleeding, infection, and venous thromboembolism. The most serious early complication is staple line leak, occurring in approximately 1–3% of cases, where gastric contents escape from the surgical staple line. This can lead to peritonitis, abscess formation, or sepsis, potentially requiring emergency intervention, prolonged hospitalisation, or further surgery.

Other peri-operative risks include adverse reactions to anaesthesia, respiratory complications (particularly in patients with sleep apnoea), and cardiovascular events. The overall mortality rate for sleeve gastrectomy in the UK is low, estimated at approximately 0.1% or lower, comparable to other commonly performed major surgical procedures.

Long-term complications may develop months or years after surgery. Gastro-oesophageal reflux disease (GORD) is relatively common, affecting 20–30% of patients, as the altered stomach anatomy can compromise the lower oesophageal sphincter. Some individuals require long-term proton pump inhibitor therapy, and severe cases may necessitate conversion to gastric bypass. Nutritional deficiencies represent another significant concern. The reduced stomach capacity and altered eating patterns can impair intake of essential vitamins and minerals, particularly vitamin B12 (due to reduced intrinsic factor production), iron, calcium, and vitamin D. Lifelong supplementation and regular blood monitoring are mandatory.

Thiamine (vitamin B1) deficiency is a serious risk, particularly if persistent vomiting occurs. Prolonged vomiting can rapidly deplete thiamine stores and lead to neurological complications. If you experience persistent vomiting, contact your bariatric team or GP urgently for assessment and possible thiamine replacement.

Gallstones may develop following rapid weight loss after surgery. Your bariatric team will discuss management options, which may include medication to reduce gallstone formation or monitoring.

Other potential long-term issues include stricture formation (narrowing of the gastric sleeve), weight regain if dietary discipline is not maintained, and rarely, the development of gastric ulcers. To reduce ulcer and leak risks, avoid non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen unless specifically advised by your doctor, and do not smoke.

Psychological challenges, including adjustment difficulties, body image concerns, or disordered eating patterns, may emerge during the weight loss phase.

You should contact NHS 111 for advice or attend your local A&E department (or call 999 in an emergency) if you experience severe abdominal pain, persistent vomiting, fever, chest pain, difficulty breathing, or signs of dehydration following surgery. Regular follow-up with the multidisciplinary bariatric team is essential for early detection and management of complications, ensuring optimal long-term outcomes and patient safety.

If you experience any suspected side effects from medicines or problems with medical devices related to your surgery, you can report these via the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk or by searching for 'Yellow Card' in the Google Play or Apple App Store.

Recovery and Long-Term Lifestyle Changes After Surgery

Recovery from sleeve gastrectomy typically follows a structured pathway. Most patients are mobilised within hours of surgery to reduce thromboembolism risk and are discharged home within one to three days if recovery is uncomplicated. Pain management is usually achieved with oral analgesics, and discomfort generally subsides within one to two weeks. Patients are advised to avoid heavy lifting and strenuous activity for four to six weeks, though gentle walking is encouraged from the outset to promote healing and prevent complications.

The post-operative diet progresses through carefully defined stages to allow the stomach to heal whilst preventing complications. Patients begin with clear fluids for the first few days, advancing to full liquids, then puréed foods, soft foods, and finally regular textured foods over approximately six to eight weeks. Portion sizes remain permanently small—typically 100–150 millilitres per meal initially—and patients must eat slowly, chew thoroughly, and stop eating at the first sign of fullness to avoid nausea, vomiting, or stretching the gastric sleeve.

Lifelong dietary modifications are essential for success. Patients must prioritise protein intake to preserve lean muscle mass during weight loss. Your dietitian will provide individualised protein goals, often around 60–80 grams daily or 1.0–1.5 grams per kilogram of ideal body weight. Limit high-calorie liquids, refined carbohydrates, and fatty foods. Adequate hydration is crucial, requiring 1.5–2 litres of fluid daily, consumed between rather than with meals. Alcohol should be limited or avoided, as tolerance is reduced and absorption is altered post-operatively.

Nutritional supplementation is mandatory for life. UK bariatric services typically follow British Obesity and Metabolic Surgery Society (BOMSS) guidance, which recommends a comprehensive daily multivitamin and mineral supplement, calcium with vitamin D, and iron as needed. Vitamin B12 supplementation is essential; many UK services recommend three-monthly intramuscular vitamin B12 injections after sleeve gastrectomy. Your bariatric team will provide specific supplementation advice tailored to your needs.

Regular blood tests are essential to monitor for deficiencies and allow timely intervention. BOMSS guidance recommends blood monitoring at three, six, and twelve months post-operatively, then annually for life. Your Tier 4 bariatric team will coordinate follow-up, often in shared care with your GP.

Medication management is important after surgery. Avoid NSAIDs (such as ibuprofen) if possible, as they increase ulcer risk. Modified-release or enteric-coated medicines may not be absorbed properly; discuss all medications with your GP or pharmacist to ensure appropriate formulations are used.

Pregnancy should be avoided for 12–18 months after surgery to allow weight to stabilise and nutritional status to be optimised. Discuss effective contraception with your GP or bariatric team, as fertility may improve with weight loss.

Physical activity is integral to maintaining weight loss and overall health. Patients should aim for at least 150 minutes of moderate-intensity exercise weekly, incorporating both cardiovascular and resistance training to preserve muscle mass and bone density.

Psychological support and behavioural modification remain important throughout the post-operative period. Many patients benefit from ongoing contact with dietitians, psychologists, or support groups to address emotional eating, body image concerns, and adjustment to their transformed lifestyle. Regular follow-up with the bariatric team—typically at three, six, and twelve months post-operatively, then annually—ensures optimal outcomes, early identification of complications, and sustained engagement with healthy behaviours. Patients should view sleeve gastrectomy as the beginning of a lifelong journey requiring commitment, discipline, and ongoing support to achieve and maintain their health goals.

Frequently Asked Questions